Biologic therapy has changed the way dermatologists treat several chronic inflammatory and autoimmune skin diseases.

While biologic therapy for psoriasis is one of the best-known uses, biologic medicines are also used for conditions such as atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria and pemphigus in appropriate patients.

What Is Biologic Therapy?

Biologics are medicines designed to target specific molecules or pathways involved in inflammation and immune-system activity.

Unlike treatments that broadly affect the immune system, many biologics are designed to act on a particular target, such as TNF, IL-17, IL-23, IL-4/IL-13 or other immune pathways.

Biologic Therapy for Psoriasis

Biologics are an important treatment option for many patients with moderate-to-severe psoriasis.

Examples include:

• Adalimumab
• Etanercept
• Infliximab
• Ustekinumab
• Secukinumab
• Ixekizumab
• Brodalumab
• Guselkumab
• Tildrakizumab
• Risankizumab
• Bimekizumab

The choice depends on disease severity, associated conditions, previous treatments and the individual patient's needs.

Biologics for Atopic Dermatitis

Biologic treatment is also used for selected patients with moderate-to-severe atopic dermatitis.

Examples include:

• Dupilumab
• Tralokinumab
• Lebrikizumab
• Nemolizumab

These medicines target immune pathways involved in the inflammation and itching associated with atopic dermatitis.

Biologics for Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic inflammatory skin condition that can cause painful nodules, abscesses and draining lesions.

Depending on the patient and local approvals, biologic options can include medicines such as:

• Adalimumab
• Secukinumab
• Bimekizumab

Biologic treatment may be considered when disease control is inadequate with other approaches.

Biologics for Chronic Spontaneous Urticaria

For some patients with chronic spontaneous urticaria that remains uncontrolled with standard treatment, biologic therapy may be considered.

Omalizumab is an important biologic used for this condition.

Biologic Therapy and Pemphigus

Biologic therapy also has a role in certain autoimmune blistering diseases.

For pemphigus, rituximab is an important biologic treatment option and is used in appropriate patients under specialist supervision.

The client-provided dermatology textbook also identifies rituximab among biologics used for immunobullous disorders and specifically notes its use in pemphigus vulgaris.

Other Skin Diseases and Biologic Research

Biologic medicines and targeted therapies continue to be studied across dermatology. Their use can vary depending on the disease, individual patient factors and regulatory approval.

This is why a biologic should not be considered a general-purpose treatment for every autoimmune skin disease.

What Are the Benefits of Biologic Therapy?

Potential biologic therapy benefits may include:

• Targeted control of inflammation
• Reduction in disease activity
• Improvement in skin symptoms
• Better control of chronic inflammatory disease
• Improved quality of life for suitable patients

The expected benefit depends on the specific disease and biologic being used.

Biologic Therapy Side Effects and Safety

Biologics can have side effects, and because they affect the immune system, infection risk is an important consideration.

Before starting treatment, a dermatologist may review medical history, medications, infections, vaccination status and relevant screening tests. Patients are also monitored during treatment.

How Does a Dermatologist Choose the Right Biologic?

There is no single biologic that is suitable for everyone.

A dermatologist for biologic treatment may consider:

• Exact diagnosis
• Disease severity
• Previous treatment response
• Other medical conditions
• Associated diseases
• Infection risk
• Current medications
• Treatment goals
• Relevant approvals and monitoring requirements

Frequently Asked Questions About Biologic Therapy

1. Are biologics used only for psoriasis?

No. Biologics are also used for selected patients with conditions such as atopic dermatitis, hidradenitis suppurativa and chronic spontaneous urticaria. Rituximab is also used in appropriate patients with pemphigus.

2. Are biologics the same for every skin disease?

No. Different biologics target different immune pathways, and their approved uses vary by disease and country.

3. Are biologic injections safe?

Biologics can be appropriate and effective for selected patients, but they have potential side effects and require medical assessment and monitoring.

4. How are biologics given?

Many biologics are given by injection, while some are administered by intravenous infusion. The schedule depends on the specific medicine.

5. Can a dermatologist prescribe biologic therapy?

Yes. Dermatologists with appropriate expertise can assess whether biologic therapy is suitable and monitor patients receiving these treatments.

Conclusion

Biologic therapy is no longer limited to psoriasis. Modern dermatology uses targeted biologic medicines for several inflammatory and immune-mediated diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, chronic spontaneous urticaria and pemphigus.

Because each biologic targets a specific pathway and has its own indications and safety considerations, treatment should be selected and monitored by an experienced dermatologist.